You are here

Advisory Committee on Complementary Medicines (ACCM)

Related information

1 December 2020

Role of the ACCM

The Advisory Committee on Complementary Medicines (ACCM) was formed in January 2010 to advise and make recommendations to the Therapeutic Goods Administration (TGA) on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods.

The Committee is established under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.

ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.

Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.



Professor Evelin Tiralongo holds dual Australian and German registrations as a pharmacist, with postgraduate degrees in pharmacognosy and biochemistry, and over 20 years of experience in pharmaceutical research in Australia and Germany. She is the Director of Griffith University's Clinical Trial Unit and the Discipline Head for Complementary Medicine Education in Pharmacy Programs at Griffith University. She has published widely, serves on several editorial boards, was a member of the National Health and Medical Research Council (NHMRC) Homeopathy Working Group and conducted CPD accredited Short Courses in Integrative Medicine for Pharmacists in Australia and New Zealand. Professor Tiralongo provides expertise in the field of pharmacognosy and biochemistry.


Professor Colin Barrow is an Alfred Deakin Professor and Chair of Biotechnology at Deakin University where he has taught and researched chemistry and biotechnology. He has a PhD in Organic Chemistry (Natural Products Chemistry) and an MBA. Over the last 10 years, Professor Barrow has led research primarily in areas of food chemistry, biotechnology and nanomaterials. In particular, he has developed methods for producing omega-3 concentrates, stabilised omega-3 delivery systems, fermentation methods for omega-3 production and methods for extracting and isolating new ingredients from agricultural and marine biomass. Professor Barrow has also worked in both the pharmaceutical and nutrition industries. Professor Barrow provides expertise in the chemistry and manufacture of complementary medicines.

Mrs Kym Child is currently working for the Tasmanian Office of Ombudsman and Health Complaints Commissioner as a Senior Investigation Officer. She has held a number of positions including as the consumer representative on the Tasmanian Pharmacy Authority and also as a lawyer on the University of Tasmania Human Research and Ethics Committee. She is currently a member of the Tasmanian Mental Health Tribunal. She has previously worked in both the Legal Unit and the Safety and Quality Unit at the Royal Hobart Hospital, as well as being a Senior Regulatory and Policy Officer in the Regulation Unit at the Tasmanian Department of Health. In addition to her legal qualification, Mrs Child is also a Registered Nurse, holding postgraduate qualifications in Paediatric Nursing and Emergency Nursing. She continues to work casually after hours as a Hospital Coordinator in the private system. Mrs Child provides expertise in the field of consumer health issues.

Dr John Edwards is a toxicologist and Occupational Hygienist with over 35 years’ experience in the University sector, and extensive experience as a consultant. His research interests have included monitoring chemical exposures in workers and in the general public. He has been president of the Australian Institute of Occupational Hygiene and is a founding member of the Australasian College of Toxicology and Risk Assessment. He has extensive experience in regulatory toxicology, and has been the Chair of the Advisory Committee on Chemicals Scheduling, has provided expert advice to the Advisory Committee on Safety of Medicines, National Health and Medical Research Council, the Department of Health and the Food Standards Australia New Zealand. Dr Edwards provides expertise in the field of toxicology.

Associate Professor Jennifer Hunter is a general practitioner and Adjunct Associate Professor of the NICM Health Research Institute, Western Sydney University. Other roles include Chair of the NHMRC Natural Therapies Working Committee, the International Society of Complementary Medicine Research elected Board of Directors and Chair of the Research Advisory Committee, and the NICM Health Research Institute, Research Committee Member. She has provided expert consultation to the World Health Organisation and serves on several editorial boards. Associate Professor Hunter provides expertise in the translation of complementary medicine evidence into primary care clinical practice, health service delivery and policy.

Dr Di Wen Lai graduated from Guangzhou University of Traditional Chinese Medicine with a Bachelor of Medicine degree. She obtained a Graduate Diploma in Preventative Medicine from Edith Cowan University, WA and studied Medical Laboratory Science at Curtin University, Western Australia. Dr Lai is a registered Chinese Medicine practitioner and has a private practice in Perth. She is a member to the Chinese Medicine Board of Australia, appointed by the Health Council of the Council of Australian Government. Dr Lai provides expertise in the field of complementary medical practice (Chinese medicine) and naturopathy.

Dr Kylie O'Brien is an Adjunct Associate Professor at Torrens University, and an Adjunct Fellow of the National Institute of Complementary Medicine Health Research Institute (Western Sydney University). She holds a PhD (Chinese Medicine), B AppSc(Chinese Medicine), MPH, BSc(Optom) and a Grad Cert Tertiary Education. Professor O'Brien previously worked for the Victorian Department of Human Services on the implementation of the Chinese Medicine Act 2000 when Chinese medicine was first regulated in Victoria. She has led the development of a Chinese herb-drug interactions database, and is currently involved in research and education in medicinal cannabis. Current roles include Director of Education at the Australasian College of Nutritional and Environmental Medicine and Chief Scientific Officer for Cannalife Pty Ltd. She also practises Chinese medicine part-time. She is a member of the World Federation of Chinese Medicine Societies' Specialty Committee for Cancer Rehabilitation. Professor O'Brien provides expertise in the field of herbal medicine and complementary medical practice (Chinese medicine).

Dr Hassan Vally is an academic with over 25 years' experience. He is an epidemiologist with experience in the analysis and interpretation of health data in addition to having expertise in the understanding and critiquing of evidence in the health domain. He has background in a number of disciplines in addition to epidemiology, including molecular biology, virology and immunology. Dr Vally provides expertise in the field of epidemiology.

2021 ACCM proposed meeting dates

Meeting no. Meeting dates
27 18 March 2021
28 15 July 2021
29 4 November 2021

Contact details for the ACCM

Complementary Medicines enquiries Committee support enquiries
Phone +61 2 6289 4627 +61 2 6289 4615 or
+61 468 609 842
Postal Address Advisory Committee on Complementary Medicines
Therapeutic Goods Administration
PO Box 100
Attn: Complementary and OTC Medicines Branch, MDP 122
Committee Support Unit
Therapeutic Goods Administration
PO Box 100
Attn: Scheduling & Committee Support Section, MDP 122